Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06374550 · ClinicalTrials.gov registry record · NA

Jump Start on the Go: Improving Resiliency and the Social-Emotional Development of At-Risk Preschool Children

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
67
Enrollment target

NCT06374550: Completed NA study, sponsored by University of Miami.

NCT06374550 is a NA study that has completed, run by University of Miami. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06374550, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target

Study Summary

The purpose of this study is to test the Jump Start on the Go (JS Go), an app-based program and see how helpful it is at improving resiliency and behavior support within childcare settings.

Primary Outcome

The Health Environment Rating Scale is a measure with a range of score from 0 to 70 with higher score indicating better classroom practices.

Interventions

  • BEHAVIORAL Jump Start on the Go
  • BEHAVIORAL Jump Start Plus Coronavirus Support

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2024-09-10
Est. Completion 2025-06-01
Phase NA
University of Miami

721 total trials

What the finished NCT06374550 record still lists

NCT06374550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Jump Start on the Go is the first listed.

NCT06374550 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06374550 about?

NCT06374550 is a clinical study titled "Jump Start on the Go: Improving Resiliency and the Social-Emotional Development of At-Risk Preschool Children". The purpose of this study is to test the Jump Start on the Go (JS Go), an app-based program and see how helpful it is at improving resiliency and behavior support within childcare settings.

What is the current status of trial NCT06374550?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2024-09-10. Estimated completion is 2025-06-01.

What interventions are being tested in trial NCT06374550?

The interventions under investigation include: Jump Start on the Go (BEHAVIORAL), Jump Start Plus Coronavirus Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06374550?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06374550's enrollment target sits among peer trials

67 1139th of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06374550, the US trial registry maintained by the National Library of Medicine. NCT06374550 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.